dial invest​

​

Dial Invest operates dialysis centres dedicated to the treatment of renal failure

About Dial Invest

​

The Dial Invest Group, now a subsidiary of Almaviva Santé, manages health establishments specialising in the treatment of Terminal Chronic Renal Failure (TCRD) by dialysis in south-eastern France. It also operates the "Clinique de l'Alma" in Paris which provides dialysis treatment, endoscopy and interventional radiology.

 

• Investment date

       October 2011

​

• Exit date

       May 2016

​

• Sector

       Healthcare

​

• Headquarters

       Aubagne (France)

​

• Sales at acquisition 

       €25m​​